Volume 70, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Ethnic differences in the outcome of hepatitis C have been described. Our aim was to investigate ethnic differences in the distribution of genotypes associated with polymorphisms of the tumor necrosis factor-α promoter, interleukin-10 promoter, and transforming growth factor-β1 leader sequence in patients with hepatitis C. Genomic DNA was obtained from 71 Egyptians and 67 Caucasians (hepatitis C and control patients). Amplification of appropriate gene segments was followed by direct sequencing. Infrequently occurring polymorphisms were identified at positions −244 and −77 of the tumor necrosis factor-α promoter and at positions −851 and −657 of the interlukin-10 promoter. The G/A genotype associated with tumor necrosis factor-α promoter positions −376 and −244 was more frequent in Egyptians ( =0.001 and =0.004, respectively). The −244 G/A genotype occurred only in healthy Egyptians ( =0.024). Thus, ethnic differences in the distribution of genotypes of the tumor necrosis factor-α promoter exist, which may have clinical implications on the outcome of hepatitis C.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Howell C, Jeffers L, Hoofnagle JH, 2000. Hepatitis C in African Americans: Summary of a workshop. Gastroenterology 119 : 1385–1396. [Google Scholar]
  2. El-Serag HB, 2002. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35 (Suppl 2): S72–S78. [Google Scholar]
  3. Mallat DB, Jeffers L, 2002. The natural history of hepatitis C in African Americans. Am J Gastroenterol 97 : 520–522. [Google Scholar]
  4. Abel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I, 2000. Hepatitis C infection in a community in the Nile Delta: Population description of HCV prevalence. Hepatology 32 : 111–115. [Google Scholar]
  5. Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Kench J, Kaba S, Crewe E, Liddle C, 2000. Which patients with hepatitis C develop liver complications. Hepatology 31 : 513–520. [Google Scholar]
  6. el-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A, 1996. Response to interferon alpha of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 3 : 261–264. [Google Scholar]
  7. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J, 1996. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 23 : 210–217. [Google Scholar]
  8. Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, Miyake T, Niigaki M, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukomoto S, 1996. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 16 : 390–399. [Google Scholar]
  9. Osna N, Silonova G, Vilgert N, Hagina E, Kuse V, Giedraitis V, Zvirbliene A, Mauricas M, Sochnev A, 1997. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood. Scand J Clin Lab Invest 57 : 703–710. [Google Scholar]
  10. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Doi Y, Yamada A, Oshikawa O, Matsuzawa Y, 1999. Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis. J Hepatol 30 : 1–7. [Google Scholar]
  11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94 : 3195–3199. [Google Scholar]
  12. Knight JC, Kwiatkowski D, 1999. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 111 : 290–298. [Google Scholar]
  13. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C, 1998. Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection. J Med Virol 54 : 173–177. [Google Scholar]
  14. Hurme M, Lahdenpohja N, Santtila S, 1998. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30 : 469–473. [Google Scholar]
  15. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV, 1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 : 1–8. [Google Scholar]
  16. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV, 1998. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 : 1014–1020. [Google Scholar]
  17. Vidigal PG, Germer JJ, Zein NN, 2002. Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 36 : 271–277. [Google Scholar]
  18. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL, 1997. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36 : 516–521. [Google Scholar]
  19. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS, 1995. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Comm 211 : 833–839. [Google Scholar]
  20. D’Alfonso S, Richiardi PM, 1994. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39 : 150–154. [Google Scholar]
  21. Zimmerman PA, Guderian RH, Nutman TB, 1996. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 44 : 485–486. [Google Scholar]

Data & Media loading...

  • Received : 23 Dec 2002
  • Accepted : 13 Mar 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error